X0609 4 2026-02-06 0 0001489993 Mobia Medical, Inc. MOBI 0001474322 Tansey Casey M false 2802 FLINTROCK TRACE, SUITE 226 AUSTIN TX 78738 1 0 1 0 0 Common Stock 2026-05-11 4 C 0 166666 A 166666 D Common Stock 2026-05-11 4 P 0 66666 15 A 233332 D Common Stock 2026-05-11 4 C 0 314090 A 314090 I See Footnote Common Stock 2026-05-11 4 C 0 3312736 A 3626826 I See Footnote Convertible Notes 2026-02-06 4 A 0 3769090.08 3769090.08 A Common Stock 314090 3769090.08 I By U.S. Venture Partners Select Fund I, L.P Convertible Notes 2026-02-10 4 A 0 2000000 2000000 A Common Stock 166666 2000000 D Stock Option 15 2026-05-07 4 A 0 31520 0 A 2026-05-07 Common Stock 31520 31520 D Convertible Notes 2026-05-11 4 C 0 3769090.08 D Common Stock 314090 0 I By U.S. Venture Partners Select Fund I, L.P Convertible Notes 2026-05-11 4 C 0 2000000 D Common Stock 166666 0 D Series F Preferred Stock 2026-05-11 4 C 0 5642738 D Common Stock 1620078 0 I See Footnote Series E-2 Preferred Stock 2026-05-11 4 C 0 5895530 D Common Stock 1692658 0 I See Footnote The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "Offering"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. After the transactions reported herein, includes (i) 1,623,245 shares of Common Stock held by U.S. Venture Partners Select Fund I, L.P. ("USVP SFI") on its own behalf and as a nominee for U.S. Venture Partners Select Fund I-A, L.P. ("USVP SFI-A" and, together with USVP SFI, the "USVP Select Funds"), (ii) 1,906,809 shares of Common Stock held by U.S. Venture Partners XII, L.P. ("USVP XII"), and (iii) 96,772 shares of Common Stock held by U.S. Venture Partners XII-A, L.P. ("USVP XII-A" and, together with USVP XII, the "USVP XII Funds"). Presidio Management Group XII, L.L.C. ("PMG XII") is the general partner of USVP XII and USVP XII-A and may be deemed to have sole voting and dispositive power with respect to the shares held by USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C. ("PMG Select") is the general partner of USVP SFI and USVP SFI-A and may be deemed to have sole voting and dispositive power with respect to the securites held by USVP SFI and USVP SFI-A. The Reporting Person is the managing partner and a managing member of each of PMG XII and PMG Select, and may be deemed to share voting and dispositive power with respect to the securites described herein. The Reporting Person disclaims beneficial ownership of such holdings, except to the extent of his pecuniary interest in the shares. Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms. This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Offering, and is reported herein pursuant to Rule 16a-2(a). The stock option will vest in three substantially equal installments on the first three anniversaries of the grant date. /s/ Chase Leavitt, Attorney-in-Fact 2026-05-11